The Business Research Company’s report on the Amusement Parks Global Market Report 2025 Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
What are the key drivers behind the premature ejaculation treatment market’s growth in recent years?
The increasing prevalence of sexual disorders is expected to propel the growth of the premature ejaculation treatment market going forward. Sexual disorder or dysfunction refers to the difficulty faced by both men and women during any phase of regular intimate activity. Premature ejaculation is a sexual disorder where premature ejaculation treatment involving medications or therapeutic approaches addresses and controls this condition. For instance, in July 2022, according to a survey of 1,000 men across the UK by Click2Pharmacy, a UK-based provider of local prescription treatment services, around 58.2% experienced erectile dysfunction in the UK and 3 in 4 men between the ages of 25 and 34 experience erectile dysfunction in 2022. Therefore, the increasing prevalence of sexual disorders is driving the growth of the premature ejaculation treatment market.
Premature Ejaculation Treatment Market Driver: Rising Awareness Of Sexual Health Fuels Premature Ejaculation Treatment Market Growth
Increasing awareness about sexual health is expected to propel the growth of the premature ejaculation treatment market going forward. Sexual health embraces holistic well-being, incorporating the physical, emotional, cognitive, and social dimensions of one’s sexuality. Awareness about sexual health is crucial for effective premature ejaculation treatment by facilitating understanding, communication, and informed decision-making. For instance, in October 2023, according to the UK Health Security Agency, a UK-based government agency, sexual health services (SHSs) witnessed a notable uptick in consultations, reaching a total of 4,394,404 in 2022. This represented an 8.2% rise from the previous year, where the count stood at 4,059,608 in 2021. Therefore, increasing awareness about sexual health is driving the growth of the premature ejaculation treatment market.
Access Your Free Sample of the Global Amusement Parks Global Market Report 2025 Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13518&type=smp
How does the future projection of the premature ejaculation treatment market size compare to its historical growth?
The premature ejaculation treatment market size has grown strongly in recent years. It will grow from $3.88 billion in 2024 to $4.27 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increasing prevalence of premature ejaculation, growing awareness and reduced stigma, physician and patient education, changing societal attitudes toward sexual health, expansion of telemedicine services, pharmaceutical industry initiatives.
The premature ejaculation treatment market size is expected to see strong growth in the next few years. It will grow to $6.16 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to continued focus on sexual health, individualized treatment approaches, global efforts to address sexual dysfunction, online health platforms and apps, increased openness in healthcare discussions. Major trends in the forecast period include rise in behavioral and psychosexual therapies, development of novel topical therapies, advancements in pharmacological treatments, integration of telemedicine and online platforms, focus on patient education and counseling, research on novel mechanisms of action.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=13518&type=smp
Which key players are shaping the future of the premature ejaculation treatment market?
Major companies operating in the premature ejaculation treatment market report are Pfizer Inc., Johnson & Johnson, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Menarini Group, Lupin Limited., Amneal Pharmaceuticals Inc., Mankind Pharma Ltd., Cipla Limited, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Ltd., ANI Pharmaceuticals Inc., Sagent Pharmaceuticals Inc., Vivus Inc., Absorption Pharmaceuticals LLC, Innovus Pharmaceuticals Inc., Sunrise Pharmaceuticals Inc., Solco Healthcare US LLC, Apricus Biosciences Inc., Regent Pacific Group Limited, Endurance RP Ltd.
What trends will propel the growth and evolution of the premature ejaculation treatment market?
Major companies operating in the premature ejaculation treatment market are developing new solutions, such as delay sprays, to drive revenues in the market. Delay sprays, specifically prepared products applied to the penis before sexual activity to assist men last longer during sexual intercourse, work by momentarily dulling penis nerves, lowering penis sensitivity, and postponing ejaculation. For instance, in August 2023, Maude, a US-based sexual wellness company, launched Stay, a delay spray explicitly designed to address premature ejaculation. This product is infused with 10% lidocaine, a fast-evaporating local anesthetic that reduces sensitivity in the male genital region. Furthermore, Stay is compatible with both latex and polyisoprene condoms, as well as various lubricants and devices. It’s vegan-friendly, fragrance-free, and free from sulfates, silicones, and parabens.
Which regions are expected to become dominant players in the premature ejaculation treatment market?
North America was the largest region in the premature ejaculation treatment market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the premature ejaculation treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
What are the emerging key segments in the premature ejaculation treatment market, and how are they evolving?
The premature ejaculation treatment market covered in this report is segmented –
1) By Type: Antidepressants (SSRIs), Phosphodiesterase-5 Inhibitors, Topical Anesthetics, Analgesics, Other Treatment
2) By Route of Administration: Oral, Topical
3) By Distribution Channel: Retail, Direct-To-Consumer
4) By Application: Hospital, Retail Pharmacy, Online Pharmacy, Other Applications
Subsegments:
1) By Antidepressants (Ssris): Paroxetine, Sertraline, Dapoxetine, Fluoxetine, Citalopram
2) By Phosphodiesterase-5 Inhibitors: Sildenafil, Tadalafil, Vardenafil, Avanafil
3) By Topical Anesthetics: Lidocaine-Based Creams, Prilocaine-Based Creams, Benzocaine-Based Sprays
4) By Analgesics: Oral Pain Relievers, Topical Pain Relievers
5) By Other Treatment: Behavioral Therapy, Counseling And Psychotherapy, Pelvic Floor Exercises, Mechanical Devices
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13518
How is the premature ejaculation treatment market defined, and what are its core characteristics?
Premature ejaculation treatment is the use of medication or therapy to address and manage premature ejaculation. Premature ejaculation treatment involves the application of medicines or therapeutic interventions to tackle and alleviate the symptoms of premature ejaculation.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
